Off-Label Use

What Makes a Use “Off-Label”

A prescription is off-label when any of these differ from FDA approval:

Approved Aspect	Off-Label Example
Indication	Using diabetes drug for weight loss (before obesity approval)
Dose	Using higher or lower than approved doses
Population	Prescribing to children when only approved for adults
Route	Using injectable form orally
Duration	Using beyond studied timeframe

Off-Label vs Approved: Peptide Examples

Semaglutide History

Year	Status
2017	Approved for type 2 diabetes (Ozempic)
2017-2021	Weight loss use was “off-label”
2021	Approved for obesity (Wegovy)
Now	Weight loss is on-label with Wegovy

Current Off-Label Peptide Uses

• Lower doses of GLP-1 agonists than approved
• Compounded semaglutide (not FDA-approved product)
• Combination protocols not studied in trials

Legality of Off-Label Prescribing

What’s Legal

• Physicians prescribing off-label based on medical judgment
• Pharmacies dispensing off-label prescriptions
• Patients using medications as prescribed

What’s Restricted

• Drug companies cannot promote off-label uses
• Marketing for unapproved indications is illegal
• Companies can only share information if asked

Why Off-Label Use Happens

Reason	Example
Approval lag	Evidence supports use before FDA reviews
Rare conditions	Not enough patients for full trials
Pediatric use	Many drugs tested only in adults
Combination therapy	Specific combinations not studied
Cost	Generic/older drug works but newer approved

Considerations for Off-Label Use

Supporting Off-Label Use

• Peer-reviewed research showing benefit
• Clinical guidelines recommending use
• Physician experience and expertise
• Patient informed consent

Concerns with Off-Label Use

• Less rigorous evidence than approval
• Insurance may not cover
• Unknown risks in new population/indication
• Liability considerations

Off-Label Use Statistics

• ~20% of all prescriptions are off-label
• Higher in certain specialties (oncology, psychiatry, pediatrics)
• Some off-label uses eventually gain approval
• Others remain off-label indefinitely

Insurance and Off-Label Use

Scenario	Coverage Likelihood
Evidence-based off-label	Sometimes covered
Compendia-listed off-label	Often covered
Experimental off-label	Rarely covered
Cosmetic off-label	Not covered

Compendia

Recognized drug references that list accepted off-label uses:

• DRUGDEX
• AHFS Drug Information
• Clinical Pharmacology Insurance may cover uses listed in these references.

Off-Label vs Compounded vs Research

Category	Definition	Legal Status
Off-label	Approved drug, unapproved use	Legal with prescription
Compounded	Custom-made version of drug	Legal from licensed pharmacy
Research chemical	Not approved for human use	Not for human consumption

Frequently Asked Questions

Is my doctor allowed to prescribe off-label?

Yes. Once FDA approves a drug, physicians can prescribe it for any use they believe benefits the patient. This is a core part of medical practice, though insurance coverage may vary.

How do I know if my prescription is off-label?

Ask your physician directly. Off-label use should be discussed with you, including why the physician believes it’s appropriate and what evidence supports it.

Is off-label use safe?

It depends on the specific use and supporting evidence. Some off-label uses have strong research support; others are more experimental. Discuss the evidence level with your prescriber.